ISOLA THERAPEUTICS INC: federal contracts won
Federal contracts of $10,000 or more awarded to this company since October 2020 (FY2021), from USAspending.gov. UEI: M3QDM72NME75
3contracts won
$8,690,416total obligated
$749,999median contract
May 01, 2026most recent start
Agencies it works for
| Agency | Contracts | Obligated |
|---|---|---|
| Department of Health and Human Services | 3 | $8,690,416 |
Where it works
Recent contracts
| Contract | Winner | Agency | Obligated | Start |
|---|---|---|---|---|
| THE PURPOSE OF THIS AWARD IS TO ADVANCE THE DEVELOPMENT OF ISOLA'S NEBULIZATION THERAPY, A MEDICAL COUNTERMEASURE DESIGNED TO PREVENT AND TR…
75A50126C00005 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Minneapolis, MN |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$7,485,417 | May 01, 2026 Ends: Oct 31, 2028 |
| R&D FOR ENDOBRONCHIAL LAVAGE (EBL) TO PREVENT AND TREAT LUNG DAMAGE FROM PULMONARY CHEMICAL AGENTS AOI #15: REDIRECT (REPURPOSING DRUGS IN R…
75A50123C00031 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Minneapolis, MN |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$749,999 | Jul 12, 2023 Ends: Jul 11, 2025 |
| PHASE I -TOPIC 431 - DRUG DELIVERY BY ENDOESOPHAGEAL LAVAGE (EEL) TO TREAT ESOPHAGEAL CANCER
75N91022C00018 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Minneapolis, MN |
— | Department of Health and Human Services National Institutes of Health |
$455,000 | Sep 15, 2022 Ends: Mar 14, 2025 |
Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.